Skip to main content
Egyptian Liver Journal
Fig. 5 | Egyptian Liver Journal

Fig. 5

From: Targeting liver cancer stem cell through EpCAM therapy targeted with chemotherapy endorse enhanced progression in hepatocellular carcinoma

Fig. 5

a In cytotoxicity assay, cisplatin alone and combination with XAV939 and (EpCAM)-treated cells shown higher cytotoxicity level than in XAV939 and shRNA (EpCAM) alone-treated cells. b Similarly, in cell viability assay, cisplatin alone and combination with EpCAM-targeted therapies shown decreased viability compared to the XAV939 alone and shRNA (EpCAM) alone treatments

Back to article page